Navigation Links
WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
Date:2/18/2010

SHANGHAI, Feb. 18 /PRNewswire-Asia-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter of 2009 after the New York Stock Exchange closes on Monday, March 8, 2010 (which will be Tuesday morning, March 9, 2010 Shanghai time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, March 9, 2010, to discuss the fourth-quarter 2009 financial results and recent business activities. The conference call may be accessed by calling:

    
    
    United States:          1-866-519-4004
    China (Landline):       800-819-0121
    China (Mobile):         400-620-8038
    Hong Kong:              800-930-346
    United Kingdom:         0-808-234-6646
    International:          +65-6733-0019
    Conference ID:          57898803

A telephone replay will be available two hours after the call's completion at:

    
    
    United States:            1-866-214-5335
    China North:              10-800-714-0386
    China South:              10-800-140-0386
    Hong Kong:                800-901-596
    United Kingdom:           0-800-731-7846
    International:            +61-2-8235-5000
    Conference ID:            57898803

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

    
    
    For more information, please contact:
    
    Ronald Aldridge
    Director of Investor Relations
    WuXi PharmaTech (Cayman) Inc.
    Tel:   +1-201-585-2048
    Email: Ron_Aldridge@wuxiapptec.com

Web: http://www.wuxiapptec.com  

SOURCE WuXi PharmaTech (Cayman) Inc.

RELATED LINKS
http://www.wuxiapptec.com

'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
4. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
5. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
6. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
7. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
8. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
9. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
10. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
11. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac ... significant negative impact on long-term patient survival, reports a team of UPMC researchers ... this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, ... public. , Dr. Maisel, founder of Retina Group of New York , ...
(Date:5/26/2016)... Indianapolis, Indiana (PRWEB) , ... May 26, 2016 ... ... national provider of healthcare supply chain solutions, today announced the organization has earned ... management meets international standards and is compliant with all rules and policies associated ...
Breaking Medicine News(10 mins):